Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral Reduction of FGFR4 with Antisense Oligonucleotides Increases Metabolic Rate and Lowers Adiposity in Diet-Induced Obese Mice
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 7, Pages e66923
Publisher
Public Library of Science (PLoS)
Online
2013-07-30
DOI
10.1371/journal.pone.0066923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- What is the prognosis for new centrally-acting anti-obesity drugs?
- (2012) David J. Heal et al. NEUROPHARMACOLOGY
- Biology's response to dieting: the impetus for weight regain
- (2011) Paul S. MacLean et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
- (2011) Matthew J. Potthoff et al. Cell Metabolism
- Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
- (2011) Mitsuhiro Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGF19 Regulates Cell Proliferation, Glucose and Bile Acid Metabolism via FGFR4-Dependent and Independent Pathways
- (2011) Ai-Luen Wu et al. PLoS One
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- Adaptive thermogenesis in humans
- (2010) M Rosenbaum et al. INTERNATIONAL JOURNAL OF OBESITY
- An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity
- (2010) F. D. Christopoulou et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Pharmacotherapy of obesity: emerging drugs and targets
- (2009) Ranjan Chakrabarti EXPERT OPINION ON THERAPEUTIC TARGETS
- Insights into energy balance from doubly labeled water
- (2009) D A Schoeller INTERNATIONAL JOURNAL OF OBESITY
- FGF15/FGFR4 Integrates Growth Factor Signaling with Hepatic Bile Acid Metabolism and Insulin Action
- (2009) Dong-Ju Shin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders
- (2009) Stefano Fiorucci et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice
- (2008) Xing Xian Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Cholesterol Feeding Prevents Hepatic Accumulation of Bile Acids in Cholic Acid-Fed Farnesoid X Receptor (FXR)-Null Mice: FXR-Independent Suppression of Intestinal Bile Acid Absorption
- (2008) M. Miyata et al. DRUG METABOLISM AND DISPOSITION
- Blockade of the Endocannabinoid System for the Reduction of Cardiometabolic Risk Factors
- (2008) Frederick F. Samaha et al. Obesity
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started